Therapeutic delivery of RNA effectors: diseases affecting the respiratory system.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmazie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1691/PH.2016.5740PMID 26867349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• siRNA delivery to the lung: what's new?

  2014cited by this paper
• Nonviral pulmonary delivery of siRNA.

  2012cited by this paper
• Development of siRNA lipoplexes for intracellular delivery in lung cancer cells

  2012cited by this paper
• Pulmonary gene delivery using polymeric nonviral vectors.

  2012cited by this paper
• Rapid translocation of nanoparticles from the lung airspaces to the body

  2010cited by this paper
• Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles

  2010cited by this paper
• Tumor-targeted delivery of siRNA by self-assembled nanoparticles.

  2008cited by this paper
• Modeling airflow and particle transport/deposition in pulmonary airways.

  2008cited by this paper
• Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer.

  2008cited by this paper
• Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells.

  2007cited by this paper
• Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.

  2007cited by this paper
• DNA transfer into human lung cells is improved with Tat-RGD peptide by caveoli-mediated endocytosis.

  2006cited by this paper
• Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes

  2006cited by this paper
• Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy

  2005cited by this paper
• Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers.

  2005cited by this paper
• Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.

  2005cited by this paper
• Ultrafine particle deposition in subjects with asthma.

  2004cited by this paper
• Aerosol Delivery of Glucosylated Polyethylenimine/Phosphatase and Tensin Homologue Deleted on Chromosome 10 Complex Suppresses Akt Downstream Pathways in the Lung of K-ras Null Mice

  2004cited by this paper
• Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres.

  2003cited by this paper
• Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo

  2001cited by this paper
• Cystic fibrosis sputum: a barrier to the transport of nanospheres.

  2000cited by this paper
• Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody.

  2000cited by this paper
• A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity

  1999cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor.

  1995cited by this paper
• The normal human lung: ultrastructure and morphometric estimation of diffusion capacity.

  1978cited by this paper
• Alveolar clearance and the role of the pulmonary lymphatics.

  1977cited by this paper
• Mucociliary tracheal transport rates in man.

  1975cited by this paper

• Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment

  2022cites this paper
• Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

  2021cites this paper
• Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps 1 identifies ORF 1 as promising target 2

  2020cites this paper
• Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target

  2020cites this paper
• Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identi�es ORF1 as promising target

  2020cites this paper
• Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles

  2019cites this paper
• Coming in and Finding Out: Blending Receptor‐Targeted Delivery and Efficient Endosomal Escape in a Novel Bio‐Responsive siRNA Delivery System for Gene Knockdown in Pulmonary T Cells

  2019cites this paper
• A Method for Targeted Nonviral siRNA Delivery in Cancer and Inflammatory Diseases.

  2019cites this paper
• Pulmonary delivery of siRNA as a novel treatment for lung diseases.

  2019cites this paper